Sayfa 2 - Piyasa Değerine Göre En Büyük Swedish (OMX) Pharmaceuticals & Biotech Hisse Senetleri

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

GÜNCELLENDİ Jun 20, 2026

Büyük sermayeli Swedish Pharmaceuticals & Biotech şirketleri üzerinde olan OMX keşfedin. Bu Pharmaceuticals & Biotech Companies Piyasa Değerine göre düzenlenmiştir.

91 şirketler

Şirket	Son Fiyat	7D Dönüş	1Y Dönüş	Piyasa Değeri	Analistlerin Hedefi	Değerleme	Büyüme	Bölünmüş Verim
FLUO	SEK 44.90	1.8%	15.1%	SEK 734.1m	SEK 73.85	2097.4	17.9%	n/a
ORX	SEK 21.00	1.4%	6.5%	SEK 733.4m	SEK 29.00	41.2	16.5%	n/a
ONCO	SEK 1.63	-8.1%	11.4%	SEK 642.7m	SEK 2.60	7.7	87.0%	n/a
SYNACT	SEK 11.66	-19.6%	-26.9%	SEK 620.5m	SEK 35.00	3.2	65.3%	n/a
ENZY	SEK 2.52	0%	-10.3%	SEK 611.7m	n/a	11.5	n/a	n/a
CANTA	SEK 2.16	0.09%	85.1%	SEK 537.5m	SEK 10.00	3.3	-54.8%	n/a
CINPHA	SEK 11.50	-5.4%	-30.6%	SEK 535.2m	SEK 46.25	7.9	-18.3%	n/a
CESSA	DKK 19.00	-2.8%	60.7%	DKK 353.0m	n/a	78.9	n/a	n/a
DICOT	SEK 0.23	-6.3%	-61.6%	SEK 468.6m	n/a	8.0	n/a	n/a
CLBIO	SEK 17.75	0.3%	80.4%	SEK 463.9m	SEK 29.00	43.5	47.3%	n/a
SPRINT	SEK 4.39	19.3%	757.4%	SEK 463.2m	SEK 4.80	5.5	3.6%	n/a
IVACC	SEK 1.30	-3.7%	35.8%	SEK 443.1m	SEK 2.10	23.5	3.8%	n/a
MOB	SEK 9.24	-8.5%	8.1%	SEK 434.3m	SEK 14.00	29.8	100.9%	n/a
ALZCUR	SEK 3.77	-11.9%	35.1%	SEK 433.2m	SEK 8.80	38.6	132.4%	n/a
ACE	SEK 3.01	6.9%	-28.7%	SEK 401.3m	SEK 5.60	4.8	104.9%	n/a
IMMU	SEK 6.30	23.5%	-6.9%	SEK 386.5m	SEK 16.00	0.7	42.1%	n/a
ISOFOL	SEK 0.68	-2.2%	-31.1%	SEK 216.7m	SEK 3.60	2.3	62.5%	n/a
XBRANE	SEK 10.30	-3.7%	-65.1%	SEK 212.2m	SEK 15.00	2.8	34.3%	n/a
ABERA	SEK 9.96	24.5%	21.5%	SEK 204.2m	n/a	17.3	n/a	n/a
KLAR	SEK 0.79	-1.0%	81.5%	SEK 195.1m	n/a	1950.6	n/a	n/a
PRO	SEK 10.20	-2.9%	-44.7%	SEK 192.7m	n/a	3.9	n/a	n/a
INIT	SEK 2.79	5.7%	-30.9%	SEK 191.0m	SEK 8.03	7.2	35.5%	n/a
NICA	SEK 0.57	3.6%	-50.9%	SEK 188.1m	SEK 1.70	7.8	50.7%	n/a
KDV B	SEK 0.28	-0.7%	-70.9%	SEK 183.6m	n/a	117.5	n/a	n/a

Page 2 of 4